Slovak Drug Regulator Recalls Heart Medication Due to Particles

The State Institute for Drug Control (ŠÚKL) in Slovakia has ordered the recall of the heart medication Levosimendan FMK 2.5 mg/ml from distributors, pharmacies, and healthcare facilities, after undesirable particles were found in an infusion solution batch.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

aktuality-skSlovak50d ago

Štátny ústav pre kontrolu liečiv sťahuje z trhu liek na srdce: V infúznom roztoku našli nežiaduce častice

Štátny ústav pre kontrolu liečiv (ŠÚKL) nariadil stiahnutie lieku Levosimendan FMK 2,5 mg/ml z úrovne distribučných spoločností, lekární aj zdravotníckych zariadení. Opatrenie sa týka šarže číslo 10825 s dátumom exspirácie august 2027.

Read full article →

Slovak Drug Regulator Recalls Heart Medication Due to Particles

Sources

Štátny ústav pre kontrolu liečiv sťahuje z trhu liek na srdce: V infúznom roztoku našli nežiaduce častice

Related Stories

Wizz Air Expands Routes to UAE and Sarajevo

LIV Golf Files for Bankruptcy Protection Following Saudi Funding Withdrawal

EU Introduces New Rules on Public Procurement and Short-Term Rentals

Chime Agrees to $590 Million Acquisition of Stride Bank